期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Value of quality of life analysis in liver cancer: A clinician's perspective 被引量:10
1
作者 Leung Li Winnie Yeo 《World Journal of Hepatology》 CAS 2017年第20期867-883,共17页
Health related quality of life(HRQOL) is increasingly recognized as an important clinical parameter and research endpoint in patients with hepatocellular carcinoma(HCC). HRQOL in HCC patients is multifaceted and affec... Health related quality of life(HRQOL) is increasingly recognized as an important clinical parameter and research endpoint in patients with hepatocellular carcinoma(HCC). HRQOL in HCC patients is multifaceted and affected by medical factor which encompasses HCC and its complications, oncological and palliative treatment for HCC, underlying liver disease, as well as the psychological, social or spiritual reaction to the disease. Many patients presented late with advanced disease and limited survival, plagued with multiple symptoms, rendering QOL a very important aspect in their general well being. Various instruments have been developed and validated to measure and report HRQOL in HCC patients, these included general HRQOL instruments, e.g., Short form(SF)-36, SF-12, Euro Qo L-5D, World Health Organization Quality of Life Assessment 100(WHOQOL-100), World Health Organization Quality of Life Assessment abbreviated version; general cancer HRQOL instruments, e.g., the European Organisation for Research and Treatment of Cancer(EORTC) QLQ-C30, Functional Assessment of Cancer Therapy(FACT)-General, Spitzer Quality of Life Index; and liver-cancer specific HRQOL instruments, e.g., EORTC QLQ-HCC18, FACT-Hepatobiliary(FACT-Hep), FACT-Hep Symptom Index, Trial Outcome Index. Important utilization of HRQOL in HCC patients included description of symptomatology and HRQOL of patients, treatment endpoint in clinical trial, prognostication of survival, benchmarking of palliative care service and health care valuation. In this review, difficulties regarding the use of HRQOL data in research and clinical practice, including choosing a suitable instrument, problems of missing data, data interpretation, analysis and presentation are examined. Potential solutions are also discussed. 展开更多
关键词 Hepatocellular carcinoma Health related quality of life Palliative care Prognosis Survival The European Organisation for Research and Treatment of cancer QLQ-C30 QLQ-HCC18 Index score functional assessment of cancer therapy EQ-5D SPITZER Short form 36 FHSI-8 World Health Organization Quality of Life assessment
下载PDF
Health-related quality of life in patients that have undergone liver resection:A systematic review and meta-analysis
2
作者 Tomohiro Ishinuki Shigenori Ota +8 位作者 Kohei Harada Hiroomi Tatsumi Keisuke Harada Koji Miyanishi MinoruNagayama Ichiro Takemasa Toshio Ohyanagi Thomas T Hui Toru Mizuguchi 《World Journal of Meta-Analysis》 2021年第1期88-100,共13页
BACKGROUND Mortality after hepatectomy has decreased,and the quality of various surgical approaches to hepatectomy have been evaluated.Various assessments of quality of life(QOL)after hepatectomy have been developed a... BACKGROUND Mortality after hepatectomy has decreased,and the quality of various surgical approaches to hepatectomy have been evaluated.Various assessments of quality of life(QOL)after hepatectomy have been developed and investigated in different clinical settings.AIM To conduct a systematic review and meta-analysis to examine two clinical topics:Laparoscopic hepatectomy vs open hepatectomy,and preoperative QOL status vs postoperative QOL status.METHODS A systematic literature search was performed using PubMed and MEDLINE,including the Cochrane Library Central.The following inclusion criteria were set for inclusion in this meta-analysis:(1)Studies comparing preoperative QOL and postoperative QOL;and(2)Studies comparing QOL between laparoscopic hepatectomy and open hepatectomy.RESULTS A total of 8 articles were included in this meta-analysis.QOL was better after laparoscopic hepatectomy than after open hepatectomy.CONCLUSION The outcomes of evaluations of QOL after hepatectomy can depend on the type of questionnaire used,the timing of the assessment,and the etiology of the hepatic disease. 展开更多
关键词 Quality of life HEPATECTOMY LAPAROSCOPY Transarterial chemoembolization functional assessment of cancer therapy–Hepatobiliary 36-Item Short-Form Health Survey European Organisation for Research and Treatment of cancer Quality of Life Core Questionnaire
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部